BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Healthy Eating and Lifestyle for Total Health

Completed

Conditions: Eating Behavior

Interventions: Other: survey

First Posted Date: 2016-04-01

Last Posted Date: 2016-04-01

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 836

Registration Number: NCT02725970

Locations: 🇺🇸
USDA/ARS Children's Nutrition Research Center, Houston, Texas, United States

Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients

Conditions: Pregnancy
Venous Thrombosis

Interventions: Other: antepartum and postpartum

First Posted Date: 2016-03-03

Last Posted Date: 2021-12-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 5

Registration Number: NCT02697123

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Hummus for Health: Dietary Quality and Health Outcomes in Toddlers

Not Applicable

Terminated

Conditions: Obesity

Interventions: Other: Lesson about vegetables
Other: Vegetables
Other: Hummus

First Posted Date: 2016-03-02

Last Posted Date: 2017-07-17

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 139

Registration Number: NCT02696278

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Smart and Secure Children Program for Preschool Obesity

Not Applicable

Completed

Conditions: Obesity
Type 2 Diabetes

Interventions: Behavioral: SSC Program
Behavioral: Written Handouts

First Posted Date: 2016-02-15

Last Posted Date: 2022-04-12

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 35

Registration Number: NCT02681874

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Pediatric Associates (TCPA), Houston, Texas, United States

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Phase 3

Recruiting

Conditions: Langerhans Cell Histiocytosis

Interventions: Drug: Cytarabine
Drug: Vinblastine/prednisone

First Posted Date: 2016-02-02

Last Posted Date: 2024-08-05

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 124

Registration Number: NCT02670707

Locations: 🇺🇸
Cook Children's Health Care System, Fort Worth, Texas, United States
🇺🇸
Vannie Cook Children's Clinic, McAllen, Texas, United States
🇺🇸
Stanford Children's Hospital, Lucile Packard Children's Hospital, Palo Alto, California, United States

and more 8 locations

Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW

Completed

Conditions: Prader-Willi Syndrome
Angelman Syndrome
Rett Syndrome
Sleep Problems

First Posted Date: 2016-02-02

Last Posted Date: 2016-02-02

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 804

Registration Number: NCT02670694

Locations: 🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States
🇺🇸
University of Florida College of Medicine, Gainesville, Florida, United States
🇺🇸
Greenwood Genetic Center, Greenwood, South Carolina, United States

and more 6 locations

Adjunctive Transcranial Direct Current Stimulation

Not Applicable

Terminated

Conditions: Chronic Pain
Psychiatric Disorders

Interventions: Device: Sham tDCS
Device: tDCS

First Posted Date: 2016-01-28

Last Posted Date: 2021-04-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 4

Registration Number: NCT02665988

Locations: 🇺🇸
The Pain Management Program at The Menninger Clinic, Houston, Texas, United States

Treatment of Adult Patients With Hemoglobin SC Disease (SCYTHE)

Phase 2

Terminated

Conditions: Hemoglobin SC Disease

Interventions: Drug: Hydroxyurea

First Posted Date: 2015-12-29

Last Posted Date: 2020-01-27

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 1

Registration Number: NCT02640573

Locations: 🇺🇸
University of Texas Houston, Houston, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation

Phase 4

Withdrawn

Conditions: Atherosclerosis

Interventions: Drug: Ticagrelor
Drug: Clopidogrel

First Posted Date: 2015-12-10

Last Posted Date: 2019-12-11

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT02626169

Locations: 🇺🇸
Baylor Clinic, Houston, Texas, United States
🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Syphilis Response to Higher Penicillin Dosage: The 2.4 Versus 7.2 Study

Phase 4

Completed

Conditions: Syphilis

Interventions: Drug: Benzathine penicillin G intramuscular 2.4 million units
Drug: Benzathine penicillin G intramuscular 7.2 million units

First Posted Date: 2015-11-23

Last Posted Date: 2016-05-17

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 64

Registration Number: NCT02611765

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy